MELA Sciences announces results of third MelaFind meeting MELA Sciences announced the results of its third company-sponsored Clinical Advisory meeting hosted during the Winter Clinical Dermatology Conference in Hawaii where technical advancements of MelaFind and future technology development opportunities were discussed and userís validated its clinical use. Retrospective data from the MelaFind pivotal study was used to investigate the MelaFind multispectral images and classifier score result as a tool to differentiate cutaneous melanoma from other pigments skin lesions. Results showed the average classifier scores of melanomas, high-grade lesions, non-melanoma skin cancers, and histologically benign nevi were 3.5, 2.7, 2.6 and 1.6 respectively. Further results showed an increase in the mean classifier score result with each additional clinical characteristic present in the lesion.
News For MELA From The Last 14 Days
Check below for free stories on MELA the last two weeks.